| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |